Crizotinib: Metastatic non-small-cell lung cancer treatment
The drug Crizotinib is used in treating patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive and relapsed or refractory, systemic anaplastic large cell lymphoma (ALCL) that is ALK-positive. Crizotinib capsules are supplied in 250 mg strength to administer orally. The common side-effects of Crizotinib are vision problems, tiredness, nausea, diarrhea, vomiting, upper respiratory infection, decreased appetite, etc.
The Crizotinib price is economical in India, and this medicine is available from certified pharmaceutical suppliers. The Indian Pharma is one of the certified and approved generic medicine suppliers, supplying medications for more than 7 years worldwide.